Todd P. Branning - 16 Mar 2022 Form 4 Insider Report for NeuBase Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/ Todd P. Branning
Issuer symbol
N/A
Transactions as of
16 Mar 2022
Net transactions value
+$33,600
Form type
4
Filing time
18 Mar 2022, 16:11:39 UTC
Previous filing
10 Jan 2022
Next filing
21 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBSE Common stock Purchase $16,200 +10,000 $1.62 10,000 16 Mar 2022 Direct
transaction NBSE Common stock Purchase $17,400 +10,000 +100% $1.74 20,000 17 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.